Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
NCT Number: NCT03198039
The primary purpose of this trial is to test the feasibility of implementing a meditation program in the perioperative period.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02215, United States
This is a prospective, randomized, controlled study involving 30 adult patients undergoing cardiac surgery. Investigators will test the feasibility of implementing a meditation program in the perioperative period. Patients will be randomized to one of three groups: those who complete Isha Kriya (IK) meditation before and after surgery, those who complete postoperative IK meditation only, and those who receive the standard of care with no meditation intervention. In addition to testing feasibility, the investigators will explore whether a meditation program can affect recovery after surgery. Patients enrolled will be followed postoperatively for up to one month to assess their cognitive function, pain, and sleep. Blood will also be collected for analysis of biomarkers of inflammation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Isha Kriya (IK) meditation approximately 12 minutes, twice a day
Time frame: Baseline through 1 month post surgery
In this descriptive, feasibility study, evaluation of feasibility will include adherence to meditation intervention (total number of sessions completed).
Time frame: Baseline and hospital discharge (approximately 5 days)
The Montreal Cognitive Assessment (MoCA) will be administered at baseline and hospital discharge. This is a validated test that measures cognitive impairment.
Time frame: Postoperative Day 1 through hospital discharge (approximately 5 days)
Postoperative pain will be assessed with a standard 11-point scale. Pain scores will be obtained by asking the subject.
Time frame: Intraoperatively through 48 hours postoperatively
The total opioid dosage received in the intraoperative period and the first 48 hours postoperatively will be abstracted from the medical record.
Time frame: Baseline and 1 month postoperatively
Changes in sleep will be measured by the Pittsburgh Sleep Quality Index (PSQI) which measures quality and patterns of sleep during the past month. This will be completed at baseline and 1 month postoperatively.
Time frame: Baseline through 1 month postoperatively
Changes in sleep will be measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance and Sleep Related Impairment questionnaires. The PROMIS sleep questionnaires assess self-reported perceptions of sleep quality and sleep impairment and will be completed weekly from baseline through 1 month postoperatively.
Time frame: Baseline, preoperatively, and Day 2 postoperatively
Blood will be collected at baseline and on postoperative Day 2 to investigate whether the use of a meditation regimen results in a reduction in inflammation and stress secondary to surgery. Subjects randomized to meditation before surgery will also have blood collected preoperatively. Specimens will be frozen for analysis at a later date.
Beth Israel Deaconess Medical Center
Other
Guided Meditation as an Adjunct to Enhance Postoperative Recovery: A Feasibility Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05564715
Amnestic Mild Cognitive Impairment - aMCI, Cognition Disorders
Dallas, Texas, United States
View Trial DetailsNCT07089654
Cognition Disorders, Cognitive Dysfunction
Jinzhou, Liaoning, China
View Trial DetailsNCT00001258
Basal Ganglia Diseases, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT07752316
Cognition Disorders, Cognitive Dysfunction
Ardabil, Iran
View Trial Details